- Home
- CDTX vs ANNA Comparison
CDTX vs ANNA Comparison
Compare CDTX & ANNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- ANNA
- Stock Information
- Founded
- CDTX 2012
- ANNA 2007
- Country
- CDTX United States
- ANNA United States
- Employees
- CDTX N/A
- ANNA N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ANNA
- Sector
- CDTX Health Care
- ANNA
- Exchange
- CDTX Nasdaq
- ANNA NYSE
- Market Cap
- CDTX 333.3M
- ANNA 366.3M
- IPO Year
- CDTX 2015
- ANNA N/A
- Fundamental
- Price
- CDTX $21.02
- ANNA $7.56
- Analyst Decision
- CDTX Strong Buy
- ANNA
- Analyst Count
- CDTX 9
- ANNA 0
- Target Price
- CDTX $41.29
- ANNA N/A
- AVG Volume (30 Days)
- CDTX 202.2K
- ANNA 6.1K
- Earning Date
- CDTX 08-12-2025
- ANNA 08-15-2025
- Dividend Yield
- CDTX N/A
- ANNA N/A
- EPS Growth
- CDTX N/A
- ANNA N/A
- EPS
- CDTX N/A
- ANNA N/A
- Revenue
- CDTX $302,000.00
- ANNA $2,064,630.00
- Revenue This Year
- CDTX N/A
- ANNA N/A
- Revenue Next Year
- CDTX N/A
- ANNA N/A
- P/E Ratio
- CDTX N/A
- ANNA N/A
- Revenue Growth
- CDTX N/A
- ANNA N/A
- 52 Week Low
- CDTX $10.14
- ANNA $4.71
- 52 Week High
- CDTX $28.42
- ANNA $18.70
- Technical
- Relative Strength Index (RSI)
- CDTX 39.72
- ANNA N/A
- Support Level
- CDTX $21.14
- ANNA N/A
- Resistance Level
- CDTX $22.60
- ANNA N/A
- Average True Range (ATR)
- CDTX 1.54
- ANNA 0.00
- MACD
- CDTX -0.51
- ANNA 0.00
- Stochastic Oscillator
- CDTX 12.57
- ANNA 0.00
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About ANNA ALEANNA INC
AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy. It is also involved in drilling, testing, and tie-in-related activities associated with three incremental Longanesi development wells.